Iran warns U.S. troops will become 'food for sharks' if Trump launches ground attack - Middle East conflict on 29 March
A senior Iranian military officer warned that American troops will become &lsq...
The World Health Organization has added GLP-1 drugs to treat diabetes to its essential medicines list, alongside treatments for cystic fibrosis and cancer, and said it hopes this will improve global access to the costly drugs.
The list, consisting of 523 medicines for adults and 374 for children, is a catalogue of the drugs the WHO believes should be available in all functioning health systems.
In the past including a drug, for instance, HIV treatments in the early 2000s, has helped to ensure access for people in poorer countries.
“Rather than letting price be a disqualifying factor, the committee views inclusion in the essential medicines list as a potential catalyst for access,” Dr Lorenzo Moja, head of the WHO secretariat overseeing the list, told Reuters.
The expert committee added the active ingredients in Novo Nordisk’s NOVOb.CO Ozempic and Eli Lilly’s LLY.N Mounjaro to the list, to treat type 2 diabetes in conjunction with established cardiovascular disease, chronic kidney disease or obesity.
The drugs were initially developed for diabetes but have also become hugely popular weight-loss drugs, under different brand names.
The WHO stopped short of adding them to treat obesity alone, as it also did in 2023.
The committee said this decision provided clear guidance on which patients would most benefit from the therapies.
“High prices of medicines like semaglutide and tirzepatide are limiting access to these medicines,” the WHO statement added, saying that encouraging generic drugmakers to produce the product would also help when patents begin to expire on the drugs next year.
Globally, more than 800 million people worldwide were living with diabetes in 2022, the WHO said. There are also more than 1 billion people with obesity.
Earlier this year, a WHO memo said it would recommend the use of the drugs for obesity, a separate step to adding them to the essential list.
The involvement of Yemen’s Houthis has heightened regional tensions as the Iran-aligned group joins the conflict. The U.S. says it is hopeful of holding talks with Iran in the coming days, while Tehran has said that "talking and bombing is intolerable". Welcome to our live coverage of the conflict.
Cuba and the United States have been at odds for more than six decades, with tensions rooted in the 1959 revolution that transformed the island’s political and economic system. Renewed focus on relations comes as Donald Trump’s rhetoric intensifies and conditions on the island worsen.
The four astronauts selected for NASA’s Artemis II mission have arrived in Florida, entering the final phase of preparations for the first crewed journey towards the Moon in more than five decades
Iranian Military Spokesman Lieutenant Colonel Ibrahim Zulfiqari has warned that American soldiers will become 'food for sharks' if U.S. President Donald Trump launches ground attacks against Iran. The threat comes after the U.S. military said it was deploying thousands of Marines to the region.
China is moving ahead with plans to establish a nationwide long-term care insurance system, aimed at supporting its rapidly ageing population and easing the financial burden on families caring for elderly relatives.
Austria’s government on Friday approved plans to introduce a nationwide ban on social media use for children under the age of 14, alongside reforms to upper secondary school curricula aimed at boosting media literacy and Artificial Intelligence (AI) education from the 2027/28 academic year.
The UK Health Security Agency (UKHSA) said that as of Wednesday evening, it has identified six new cases of meningococcal disease in Kent, bringing the total of confirmed or suspected cases to at least 27.
The Scottish Parliament has voted against legalising assisted dying, ending a years-long campaign to make Scotland the first part of the UK to allow the practice.
The war in the Middle East is beginning to disrupt the flow of critical medicines to Gulf countries, raising concerns about the supply of cancer treatments and other temperature-sensitive drugs, according to pharmaceutical industry executives.
The World Health Organization (WHO) has released $2m in emergency funding to support health responses in Lebanon, Iraq and Syria as escalating regional conflict strains hospitals, raises displacement and increases pressure on already fragile health systems.
You can download the AnewZ application from Play Store and the App Store.
What is your opinion on this topic?
Leave the first comment